Minerva Neurosciences | NERV - Рыночная капитализация





Рыночная капитализация Изменить Дата
Acadia Pharmaceuticals USD 3.8B 724M 2026-03
Adma Biologics USD 2.15B 2.19B 2026-03
ALKERMES USD 5.88B 1.26B 2026-03
Alterity Therapeutics Limited AUD 47M 9M 2026-07
AstraZeneca USD 301.25B 13.1B 2026-03
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Cipla INR 988.89B 231.9B 2026-03
Clal Biotechnology ILS 43.45M 8.92M 2026-03
Compugen USD 573.66M 46.63M 2026-07
CSL USD 55.89B 20.42B 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Esperion Therapeutics USD 885M 351M 2025-12
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Halozyme Therapeutics USD 7.66B 257M 2026-03
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
J&J USD 579.15B 78.91B 2026-03
Merck USD 297.1B 35.84B 2026-03
Neurocrine Biosciences USD 13.25B 890M 2026-03
Novartis USD 307.76B 15.54B 2026-03
Novavax USD 1.09B 316M 2025-12
Pfizer USD 153.81B 12.24B 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.27B 605.48M 2026-03
Takeda JPY 9.01T 1.37T 2026-03
Vanda Pharmaceuticals USD 279M 6M 2024-12